Company Website

Contact Information:

Return to Virtual Exhibit Hall

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.

OCREVUS (ocrelizumab)

ENSPRYNG (SATRALIZUMAB-MWGE)

Evrysdi (risdiplam)